[Erythroderma induced by teicoplanin]
- PMID: 1285594
[Erythroderma induced by teicoplanin]
Abstract
We report the case of a 38-year old man who developed erythroderma during treatment with teicoplanin for staphylococcal septicaemia. The clinical symptoms, which included high fever, shock and erythroderma, were suggestive of staphylococcal toxic shock. After teicoplanin was withdrawn and replaced by vancomycin the disease followed a favourable course. The reintroduction test was positive. This case illustrates the problems associated with the diagnosis of erythroderma in intensive care patients and confirms that it is possible to prescribe vancomycin in cases with allergic reaction to teicoplanin.
Similar articles
-
Vancomycin-induced neutropenia resolves after substitution with teicoplanin.Clin Infect Dis. 2000 Sep;31(3):824-5. doi: 10.1086/314028. Clin Infect Dis. 2000. PMID: 11017842
-
Effectiveness of teicoplanin versus vancomycin lock therapy in the treatment of port-related coagulase-negative staphylococci bacteraemia: a prospective case-series analysis.Int J Antimicrob Agents. 2009 Nov;34(5):482-5. doi: 10.1016/j.ijantimicag.2009.06.020. Epub 2009 Aug 26. Int J Antimicrob Agents. 2009. PMID: 19713086
-
[Case of congestive heart failure associated with hypereosinophilia developed during antibiotics treatment].Arerugi. 2005 Oct;54(10):1208-12. Arerugi. 2005. PMID: 16407668 Japanese.
-
Teicoplanin-induced hypersensitivity syndrome with a preceding vancomycin-induced neutropenia: a case report and literature review.J Clin Pharm Ther. 2010 Dec;35(6):729-32. doi: 10.1111/j.1365-2710.2009.01124.x. J Clin Pharm Ther. 2010. PMID: 21054466 Review.
-
Severe staphylococcal knee arthritis responding favourably to linezolid, after glycopeptide-rifampicin failure: a case report and literature review.Scand J Infect Dis. 2005;37(6-7):513-7. doi: 10.1080/00365540510036589. Scand J Infect Dis. 2005. PMID: 16012016 Review.
Cited by
-
Teicoplanin. A reappraisal of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy.Drugs. 1994 May;47(5):823-54. doi: 10.2165/00003495-199447050-00008. Drugs. 1994. PMID: 7520860 Review.
-
Teicoplanin. A pharmacoeconomic evaluation of its use in the treatment of gram-positive infections.Pharmacoeconomics. 1995 Apr;7(4):357-74. doi: 10.2165/00019053-199507040-00009. Pharmacoeconomics. 1995. PMID: 10155323 Review.